A Houston neurologist had his medical license suspended following his arrest on charges that accuse him of soliciting a minor ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared ...

"Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so," ...

Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...